Discover 572 paid clinical trials in Oklahoma City, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Oklahoma City offers many opportunities for both healthy volunteers and individuals with specific health concerns to participate in clinical research. Participants have the opportunity to explore innovative treatments and contribute to the advancement of medical science for conditions such as depression, pulmonary fibrosis, and various neurological disorders.
Filter
2
Filter results
Results: 572
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
for
Interstitial Lung Disease
Location: Oklahoma City OK, Dallas TX, Houston TX, New Orleans LA,
Sponsor: aTyr Pharma, Inc.
Sex: All
Age: 18+
Code: NCT05892614
Phase 2, Recruiting
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
for
Relapsing Multiple Sclerosis
Location: Oklahoma City OK, Overland Park KS, St Louis MO,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT05877963
Phase 3, Recruiting
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Location: Oklahoma City OK, Dallas TX, San Antonio TX, Houston TX,
Sponsor: Normunity AccelCo, Inc.
Sex: All
Age: 18+
Code: NCT07182149
Phase 1, Recruiting
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
for
Growth Hormone Deficiency (GHD)
Location: Oklahoma City OK, Fort Worth TX, Amarillo TX,
Sponsor: Lumos Pharma
Sex: All
Age: 3 - 11
Code: NCT06948214
Phase 3, Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Oklahoma City OK, Sherman TX, Wichita KS, McKinney TX,
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations